全文获取类型
收费全文 | 1244篇 |
免费 | 114篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 55篇 |
妇产科学 | 24篇 |
基础医学 | 271篇 |
口腔科学 | 11篇 |
临床医学 | 123篇 |
内科学 | 280篇 |
皮肤病学 | 13篇 |
神经病学 | 133篇 |
特种医学 | 26篇 |
外科学 | 96篇 |
综合类 | 5篇 |
预防医学 | 111篇 |
眼科学 | 6篇 |
药学 | 104篇 |
中国医学 | 1篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 15篇 |
2022年 | 25篇 |
2021年 | 46篇 |
2020年 | 22篇 |
2019年 | 44篇 |
2018年 | 42篇 |
2017年 | 33篇 |
2016年 | 39篇 |
2015年 | 47篇 |
2014年 | 51篇 |
2013年 | 62篇 |
2012年 | 121篇 |
2011年 | 113篇 |
2010年 | 54篇 |
2009年 | 34篇 |
2008年 | 68篇 |
2007年 | 81篇 |
2006年 | 82篇 |
2005年 | 59篇 |
2004年 | 65篇 |
2003年 | 58篇 |
2002年 | 48篇 |
2001年 | 8篇 |
2000年 | 3篇 |
1999年 | 8篇 |
1998年 | 10篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1993年 | 4篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1975年 | 2篇 |
1974年 | 7篇 |
1960年 | 2篇 |
1959年 | 2篇 |
1956年 | 2篇 |
1955年 | 2篇 |
1938年 | 2篇 |
排序方式: 共有1366条查询结果,搜索用时 15 毫秒
81.
Behnke K Søgaard J Martin S Bäuml J Ravindran AV Agren H Vester-Blokland ED 《Journal of clinical psychopharmacology》2003,23(4):358-364
This multinational, randomized, double-blind study was specifically designed to prospectively compare the onset of antidepressant efficacy of mirtazapine orally disintegrating tablets and sertraline at dosages commonly used in clinical practice. A total of 345 patients with major depressive episode (DSM-IV) received mirtazapine (30-45 mg/d) or sertraline (50-150 mg/d) for 8 weeks. Mirtazapine was administered in the newly developed fast dissolving, orally disintegrating tablet formulation. Assessments were performed at baseline and on days 4, 7, 10, 14, 28, 42, and 56. The primary efficacy variable (mean absolute change from baseline in the Hamilton Depression Rating Scale [HAMD] total score [17 items]) showed that mirtazapine was significantly (P < 0.05) more effective than sertraline at all assessments during the first 2 weeks of the study. After this time, HAMD total scores were similar in both groups. These findings were supported by analysis of the HAMD response rate (ie, > or =50% reduction in HAMD total score from baseline), HAMD remission rate (HAMD total score of < or =7), and the Montgomery-Asberg Depression Rating Scale (MADRS). Both treatments were well tolerated. In addition, mirtazapine had a greater effect than sertraline on sexual functioning. In conclusion, this first prospective onset of action study using the orally disintegrating tablet indicates that mirtazapine has a faster onset of therapeutic effect than sertraline. The orally disintegrating tablet formulation of mirtazapine used in this study is known to enhance the convenience and compliance by the patient. 相似文献
82.
Reg IV,a new member of the regenerating gene family,is overexpressed in colorectal carcinomas 总被引:8,自引:0,他引:8
Violette S Festor E Pandrea-Vasile I Mitchell V Adida C Dussaulx E Lacorte JM Chambaz J Lacasa M Lesuffleur T 《International journal of cancer. Journal international du cancer》2003,103(2):185-193
A better understanding of the mechanisms by which colon tumor cells are able to survive exposure to drugs would be valuable for the development of new therapeutic strategies. We used differential display-PCR to compare gene expression in the drug-sensitive HT-29 colon cancer cell line and 3 drug-resistant subpopulations derived from this parental cell line. One of the genes identified is a new gene, Regenerating IV gene (Reg IV), and was strongly overexpressed in HT-29 drug-resistant cells. Other drug-resistant cell lines expressed Reg IV at a high level, whereas a low expression was noted in sensitive cell lines. Northern blot and real-time PCR analysis showed that Reg IV is more strongly expressed in 71% of colorectal tumors (in particular in mucinous carcinomas) than in normal colon tissues. The comparison of Reg IV expression with that of other REG genes, Regenerating Ialpha or (Reg Ialpha), Regenerating Ibeta (Reg Ibeta) and Pancreatitis-associated protein (PAP), highlights its predominant expression in colorectal tumors. Reg IV mRNA-positive tumor cells display different phenotypes: mucus-secreting, enterocyte-like or undifferentiated. Interestingly, whereas Reg IV expression is low in normal colon, its level in normal small intestine is similar to that in some colorectal tumors. In normal tissue, Reg IV mRNA-positive cells are mostly enteroendocrine cells and goblet cells. Our results point out the potential role of Reg IV in colorectal tumors and its subsequent interest as a pronostic indicator of tumor survival. 相似文献
83.
Botton E Saraux A Laselve H Jousse S Le Goff P 《Joint, bone, spine : revue du rhumatisme》2003,70(5):327-335
Although bone and joint manifestations are common in children with cystic fibrosis (CF), they have received little attention in adults. As compared to healthy individuals, bone mineral density is low, even with calcium intakes greater than 1500 mg/d. Nevertheless, calcium and phosphate levels in blood and urine are often normal, and vitamin D levels vary. Short stature with a low body mass index and central hypogonadism are the rule in these patients. Fractures and kyphosis are often reported. CF arthropathy occurs in 2-8.5% of patients. Arthritis develops, and there may be skin eruptions. Non-steroidal antiinflammatory drug therapy is effective. Hypertrophic osteoarthropathy associated with respiratory failure is present in 2-7% of patients. Rheumatoid arthritis, spondyloarthropathies, sarcoidosis, and amyloidosis have been reported in association with CF. Knee pain due to patellofemoral syndrome, quinolone-induced arthropathy, and mechanical back pain have been described. Rheumatoid factor titers are higher than in healthy controls, particularly in patients with episodic arthritis. No data are available on antiperinuclear factor or antikeratin antibody titers. Tests for antinuclear antibody are usually negative. Circulating immune complex levels and antibodies to heat shock proteins may be elevated. Antineutrophil cytoplasmic antibody of the bactericidal/permeability-increasing protein (BPI) or azurocidin (AZ) type has been reported, often in high titers (up to 40%). 相似文献
84.
85.
Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice 总被引:6,自引:0,他引:6
Rousselet E Joubert C Callebert J Parain K Tremblay L Orieux G Launay JM Cohen-Salmon C Hirsch EC 《Neurobiology of disease》2003,14(2):218-228
Behavioral analyses of mice intoxicated by the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) have generated conflicting results. We therefore analyzed the relationship between behavioral changes, loss of monoamine levels, and loss of dopaminergic cell bodies in groups of mice intoxicated with acute or subchronic MPTP protocols. Despite a higher degree of neuronal loss in the mice intoxicated using subchronic protocols, dopamine loss was severe and homogeneous in the striatum in all groups. Dopamine levels were less severely reduced in the frontal cortex in the three groups of MPTP-intoxicated mice. Norepinephrine and serotonin levels in the striatum were decreased only in the mice intoxicated with the acute protocol. The most surprising result was that the mice intoxicated with the subchronic protocols were more active than the saline-treated mice. As reported in rats with dopamine depletion in the prefrontal cortex, the hyperactivity observed in our mice could be due to the reduced dopamine levels detected in this structure. 相似文献
86.
87.
88.
Zsuzsa Iffiú-Soltész Estelle Wanecq Almudena Lomba Maria P. Portillo Federica Pellati Éva Szökő Sandy Bour John Woodley Fermin I. Milagro J. Alfredo Martinez Philippe Valet Christian Carpéné 《Pharmacological research》2010,61(4):355-363
Benzylamine is found in Moringa oleifera, a plant used to treat diabetes in traditional medicine. In mammals, benzylamine is metabolized by semicarbazide-sensitive amine oxidase (SSAO) to benzaldehyde and hydrogen peroxide. This latter product has insulin-mimicking action, and is involved in the effects of benzylamine on human adipocytes: stimulation of glucose transport and inhibition of lipolysis. This study examined whether chronic, oral administration of benzylamine could improve glucose tolerance and the circulating lipid profile without increasing oxidative stress in overweight and pre-diabetic mice. The benzylamine diffusion across the intestine was verified using everted gut sacs. Then, glucose handling and metabolic markers were measured in mice rendered insulin-resistant when fed a high-fat diet (HFD) and receiving or not benzylamine in their drinking water (3600 μmol/(kg day)) for 17 weeks. HFD-benzylamine mice showed lower body weight gain, fasting blood glucose, total plasma cholesterol and hyperglycaemic response to glucose load when compared to HFD control. In adipocytes, insulin-induced activation of glucose transport and inhibition of lipolysis remained unchanged. In aorta, benzylamine treatment partially restored the nitrite levels that were reduced by HFD. In liver, lipid peroxidation markers were reduced. Resistin and uric acid, surrogate plasma markers of metabolic syndrome, were decreased. In spite of the putative deleterious nature of the hydrogen peroxide generated during amine oxidation, and in agreement with its in vitro insulin-like actions found on adipocytes, the SSAO-substrate benzylamine could be considered as a potential oral agent to treat metabolic syndrome. 相似文献
89.
Simohamed Belmouaz Estelle Desport Fannie Leroy Julie Teynie Jér?me Hannequin Ramzi Abou Ayache Frank Bridoux Guy Touchard 《Nephrology, dialysis, transplantation》2008,23(1):417-419
Sir, Intravenous immunoglobulin (IvIg) is commonly used in nephrologyunits for the treatment of auto-immune diseases, antibody-mediatedrenal allograft rejection and immune deficiencies. Minor adverseeffects, such as myalgia, headache, shiver, nausea, vomitingor fever occur in <20% of patients. Major reactions includingrenal failure, thromboembolism, aseptic meningitis and anaphylaxisare less common. Whereas osmotic nephropathy resulting frommaltose and saccharose toxicity is well-known to nephrologists,posterior reversible encephalopathy syndrome (PRES) is a rareand potentially severe adverse event of IvIg therapy. A 42-year-old man was admitted 相似文献
90.